Liberian Doctor Treated With Experimental Ebola Drug ZMapp Dies

News outlets report on a Liberian doctor who has died of Ebola despite being treated with the experimental drug ZMapp.

Agence France-Presse: Liberian medic treated with experimental Ebola drug dies
“A Liberian doctor treated with experimental American anti-Ebola serum ZMapp has died, a minister in the West African nation said on Monday…” (8/25).

Associated Press: Liberia: Doctor given experimental Ebola drug dies
“…Dr. Abraham Borbor, the deputy chief medical doctor at Liberia’s largest hospital, had received ZMapp, along with two other Liberians. He ‘was showing signs of improvement but yesterday he took a turn for the worse,’ and died Sunday, Information Minister Lewis Brown told the Associated Press…” (Paye-Layleh/Gillies, 8/25).

New York Times: Liberian Doctor Treated With an Experimental Drug Dies From Ebola
“A Liberian doctor with Ebola who was given ZMapp — the same experimental drug given to two infected Americans — has died, officials said Monday…” (McNeil, 8/25).

Reuters: Liberian doctor who received rare Ebola drug ZMapp dies
“…Abraham Borbor’s death could curb optimism about the drug that mounted last week when two U.S. aid workers who caught Ebola in Liberia were declared free of the virus after receiving the same treatment at a hospital in the United States…” (MacDougall, 8/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.